Synjardy XR 12.5 mg/1

Synjardy XR 12.5 mg/1 combines empagliflozin and metformin hydrochloride for blood sugar management. This extended-release tablet supports glucose control in adults with type 2 diabetes.

Synjardy XR 12.5 mg/1 is used to improve blood sugar levels in adults with type 2 diabetes. It works by helping the kidneys remove excess glucose and reducing glucose production in the liver. This medication is often part of a broader treatment plan that includes diet and exercise.

Common effects of Synjardy XR 12.5 mg/1 may include urinary tract infections, nausea, and diarrhea. Some users may experience low blood sugar, especially when combined with other diabetes medications. Always consult a healthcare provider for personalized advice.

Handle Synjardy XR 12.5 mg/1 with care, especially if you have kidney issues or are prone to dehydration. Avoid alcohol while taking this medication, as it can increase the risk of side effects. Store in a cool, dry place away from children.

Synjardy XR 12.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.